Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: The study aimed to investigate the effects of Temporoparietal Fascia trigger point release in subjects with Tension Type Headache (TTH) and on decreasing pain intensity and head and neck disability.
Methods: 40 subjects were randomly assigned to either Group 1 (intervention group) or Group 2 (control group) and received treatment for 10 days. Outcome measures, including the Visual Analog Scale (VAS) for pain intensity, Neck Disability Index (NDI) for neck disability, Headache Disability Inventory (HDI) for headache disability, and Pressure Pain Threshold (PPT) were used. Assessments were conducted in both groups before and after the 10-day intervention period.
Result: Both groups exhibited statistically significant improvements in pain intensity, neck and headache disability, and pressure pain threshold after 10 days of intervention ( = 0.001). However, the intervention group showed greater clinical improvement compared to the control group. Between-group analysis revealed significant differences favoring the intervention group in VAS ( = 10.63), NDI ( = 7.81), HDI ( = 8.00), and PPT ( = 2.60), indicating that trigger point release in the temporo-parietal fascia was more effective in reducing symptoms and enhancing pain threshold.
Conclusion: The study concluded that Myofascial trigger points (MTrPs) release is notably effective in pain reduction, as evidenced by greater clinical improvement in the intervention group compared to the control group. Both groups experienced similar benefits in reducing head and neck-related disabilities and increasing pain pressure thresholds.
Clinical Trial Registration: www.ctri.nic.in, identifier: CTRI/2023/06/054085.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12320840 | PMC |
| http://dx.doi.org/10.1080/17581869.2025.2527616 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Nurses' Self-Reported Practices and Prescribers' Expectations in Intravenous Fluid Therapy for Hospitalised Patients: A Survey Study and Clinical Documentation Review.
J Adv Nurs
September 2025
Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Aims: To assess self-reported practices and knowledge of nurses and prescribers (i.e., physicians and nurse practitioners) on intravenous fluid therapy, and to evaluate how this is documented through a clinical documentation review.
View Article and Find Full Text PDFDigital Cueing With Laser Shoes Does Not Improve Walking in Parkinson's Disease: Evidence Across Disease Severity and Freezing Status.
Neurorehabil Neural Repair
September 2025
Department of Sport, Exercise and Rehabilitation, Northumbria University, Newcastle upon Tyne, UK.
Background: Gait impairment in Parkinson's disease (PD) occurs early and pharmaceutical interventions do not fully restore this function. Visual cueing has been shown to improve gait and alleviate freezing of gait (FOG) in PD. Technological development of digital laser shoe visual cues now allows for visual cues to be used continuously when walking.
View Article and Find Full Text PDFTiming Matters: How Daily Rhythms Affect Remote Ischemic Postconditioning Therapy for Stroke.
Stroke
September 2025
Departments of Radiology and Neurology, Neuroprotection Research Laboratories, Massachusetts General Hospital, Harvard Medical School, Boston (E.L., R.M.P., K.H., E.H.L., E.E.).
Background: Despite promising preclinical results, remote limb ischemic postconditioning efficacy in human stroke treatment remains unclear, with mixed clinical trial outcomes. A potential reason for translational difficulties could be differences in circadian rhythms between nocturnal rodent models and diurnal humans.
Methods: Male C57BL/6J mice were subjected to transient focal cerebral ischemia and then exposed to remote postconditioning during their active or inactive phase and euthanized at 24 hours and 3 days.
Buprenorphine Adherence Trajectories and Their Impact on Opioid Overdose and Healthcare Costs.
Drug Alcohol Rev
September 2025
The Prescription Drug Misuse Education and Research (PREMIER) Center, University of Houston, Houston, Texas, USA.
Introduction: Buprenorphine is effective for opioid use disorder (OUD), yet adherence remains suboptimal. This study aimed to identify adherence trajectories, explore their predictors, and assess their association with opioid overdose risk and healthcare costs.
Methods: A retrospective cohort study was conducted using the Merative MarketScan Commercial Database, which includes a nationally representative sample of individuals with private, employer-sponsored health insurance in the United States.
Season of Blood Pressure Measurement Screening and All-Cause Mortality: A Community-Based Prospective Cohort Study.
Hypertension
September 2025
Department of Hypertension, Center for Epidemiological Studies and Clinical Trials, the Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China (J.W.).
Background: The association between season of screening blood pressure (BP) measurement and adverse outcomes has not been examined among populations without prior physician-diagnosed hypertension. We aimed to investigate the association between the season of screening clinic BP measurement and the risk of all-cause mortality.
Methods: This was a prospective cohort study, and data were analyzed from an ongoing community hypertension screening program in Shanghai between 2018 and 2024.